北京某医院侵袭性念珠菌感染的菌株分布及药敏分析

中国真菌学杂志　 2020, Vol. 15 　Issue (6): 359-363,370.

北京某医院侵袭性念珠菌感染的菌株分布及药敏分析

杨靖娴¹, 邵冬华¹, 郭莉娜², 刘静¹, 徐英春², 梁国威¹

1. 航天中心医院检验科, 北京 100049;
2. 中国医学科学院北京协和医院检验科侵袭性真菌病机制研究与精准诊断北京市重点实验室, 北京 100730

收稿日期:2019-12-02 发布日期:2020-12-28
通讯作者: 梁国威,E-mail:lgw721@163.com E-mail:lgw721@163.com
作者简介:杨靖娴,女(汉族),硕士,副主任技师.E-mail:yangjx5680@163.com
基金资助:
首都卫生发展科研专项（2016-1-4013）

Species distribution and antifungal susceptibility test of invasive Candida infection in a hospital in Beijing

YANG Jing-xian¹, SHAO Dong-hua¹, GUO Li-na², LIU Jing¹, Xu Ying-chun², LIANG Guo-wei¹

1. Department of Clinical Laboratory, Aerospace Center Hospital, Beijing 100049, China;
2. Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China;Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing 100730, China

Received:2019-12-02 Published:2020-12-28

摘要/Abstract

摘要： 目的调查北京某医院侵袭性念珠菌感染的菌株分布和药敏特点，为临床合理使用抗真菌药物提供依据。方法收集该医院4年间（2012-2013年，2016-2017年）临床分离的126株侵袭性念珠菌菌株，对菌种构成进行分析，采用微量肉汤稀释法对7种抗真菌药物进行药敏分析。结果 126株念珠菌中，白念珠菌比例最高，占38.10%，非白念株菌以光滑念珠菌比例最高（30.95%），其次为热带念珠菌（18.25%）和近平滑念珠菌（11.11%）。白念珠菌和近平滑念珠菌对两性霉素B、唑类和棘白菌素类药物的敏感率（野生型率）接近100%。而光滑念珠菌和热带念珠菌对氟康唑（10.26%和30.43%）和伏立康唑（48.72%和26.09%）均表现出较高的耐药率（非野生型率），但对两性霉素B和棘白菌素类药物的敏感率（野生型率）>92%。结论我院侵袭性念珠菌感染中，非白念珠菌的分离率已高达61.90%。两性霉素B和棘白菌素类可用于侵袭性念珠菌感染的经验治疗，对光滑念珠菌和热带念珠菌引起的感染应谨慎使用唑类药物。

关键词: 侵袭性念珠菌感染, 菌株分布, 药敏试验

Abstract: Objective To investigate the species distribution and antifungal susceptibility of invasive candida infection in a hospital in Beijing, and to provide evidence for rational use of antifungal drugs. Methods Totally 126 strains of invasive candida isolates were collected from the hospital during 2012-2013 and 2016-2017, and the composition of the strains were analyzed. The susceptibility of 7 antifungal drugs was analyzed by microbroth dilution method. Results Of the 126 Candida strains, C.albicans was the most predominant, accounting for 38.10%. Of the non-C.albicans strains, C.glabrata was the most common with a frequency of 30.95%, followed by C.tropicalis (18.25%) and C.parapsilosis (11.11%), respectively. The susceptibility (wild type) rates of C.albicans and C.parapsilosis to amphotericin B and echinomycins were close to 100%. The resistance (non wild type) rates of C.glabrata and C.tropicalis to fluconazole (10.26% and 30.43%) and voriconazole (48.72% and 26.09%) were showed in higher levels, while the susceptibility (wild type) rates of C.glabrata and C.tropicalis to amphotericin B and echinomycins were >92%. Conclusion The frequency of non-C.albicans in invasive Candida infection was up to 61.90%. Amphotericin B and echinomycins could be used for the empirical treatment of invasive Candida infection, while azoles should be used with caution for C.glabrata and C.tropicalis infections.

Key words: invasive Candida infection, species distribution, antifungal susceptibility test

中图分类号:

R519.3

杨靖娴, 邵冬华, 郭莉娜, 刘静, 徐英春, 梁国威. 北京某医院侵袭性念珠菌感染的菌株分布及药敏分析[J]. 中国真菌学杂志, 2020, 15(6): 359-363,370.

YANG Jing-xian, SHAO Dong-hua, GUO Li-na, LIU Jing, Xu Ying-chun, LIANG Guo-wei. Species distribution and antifungal susceptibility test of invasive Candida infection in a hospital in Beijing[J]. Chinese Journal of Mycology, 2020, 15(6): 359-363,370.

参考文献

[1] Pu S, Niu S, Xu S,et al. Epidemiology, antifungal susceptibilities and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China[J]. J Microbiol Immunol Infect, 2017, 50(1):97-103.
[2] Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia:a systematic review of matched cohort and case control studies[J]. Eur J Clin Microbiol Infect Dis, 2006, 25(7):419-425.
[3] 曹彬, 王辉, 巫琳, 等. 侵袭性念珠菌院内感染的流行病学调查[J]. 中华医学杂志, 2008, 28(88):1970-1973.
[4] Xiao M, Sun ZY, Kang M,et al. Five-year national surveillance of invasive candidiasis:species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study[J]. J Clin Microbiol, 2018, 56(7):e00577-18.
[5] Arnold HM, Micek ST, Shorr AF,et al. Hospital resource utilization and costs of inappropriate treatment of candidemia[J]. Pharmacotherapy, 2010, 30(4):361-368.
[6] CLSI, M27-A3. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard, 3rd ed[S]. Clinical and Laboratory Standards Institute, Wayne, PA. 2009.
[7] CLSI, M60. Performance standards for antifungal susceptibility testing of yeasts, 1st ed[S]. Clinical and Laboratory Standards Institute, Wayne, PA. 2018.
[8] CLSI, M59. Epidemiological cutoff values for antifungal susceptibility testing, 2nd ed[S]. Clinical and Laboratory Standards Institute, Wayne, PA. 2018.
[9] Guo LN, Xiao M, Cao B,et al. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China[J]. Future Microbiol, 2017, 12(12):1075-1086.
[10] 王贺, 徐英春. 中国多中心侵袭性酵母样真菌感染临床相关科学研究方法体系的探索和建立[D]. 北京协和医学院, 2017.
[11] 杨继勇, 张军民, 周贵民. 深部酵母菌感染的病原学特征及其药物敏感性[J]. 检验医学, 2004, 19(6):546-549.
[12] 田洹. 2015~2017年某医院念珠菌感染及其耐药性分析[J]. 中国真菌学杂志, 2019, 14(1):37-41.
[13] Guo F, Yang Y, Kang Y, et a1. Invasive candidiasis in intensive care units in China:a multicentre prospective observational study[J]. J Antimicrob Chemother, 2013, 68(7):1660-1668.
[14] 栗方, 李志荣, 赵颖, 等. 河北地区侵袭性酵母样真菌的菌株分布及药敏分析[J]. 中国真菌学杂志, 2019, 14(4):222-227.
[15] 熊志刚, 曹文, 陈中举,等. 深部酵母菌感染分布及耐药性分析[J]. 检验医学与临床, 2017, 14(9):1218-1219, 1223.
[16] 郭莉娜, 徐志鹏, 王瑶, 等. 微量肉汤稀释法比较分析不同培养时间念珠菌属对唑类药物的敏感性[J]. 中国真菌学杂志, 2016, 11(6):332-336.
[17] CLSI, M27-S4. Reference method for broth dilution antifungal susceptibility testing of yeasts, fourth informational supplement[S]. Clinical and Laboratory Standards Institute, Wayne, PA. 2012.